EUVIMEDEUVIMED entdecken
Crossref

Thiazolopyrimidinone Derivative H5–23 Enhances Daptomycin Activity against Linezolid-Resistant Enterococcus faecalis by Disrupting the Cell Membrane

Yanpeng Xiong iD, Zhong Chen iD, Bing Bai, Yalan Peng, Shanghong Liu, Di Fang, Zewen Wen iD, Yongpeng Shang, Zhiwei Lin, Shiqing Han, Zhijian Yu

ACS Infectious Diseases · 08.12.2023 · 9 (12) · 2523-2537

DOI: 10.1021/acsinfecdis.3c00387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 28.11.2023. Verfasst von Yanpeng Xiong und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China. Hauptthemen laut MEDLINE: Daptomycin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Science, Technology and Innovation Commission of Shenzhen Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DaptomycinAnimalsMiceLinezolidEnterococcus faecalisAnti-Bacterial AgentsEnterococcusCell Membrane

Stichwörter der Autor:innen

H5–23antibiotic resistancebiofilmscell membranelinezolid-resistant E. faecalis

Substanzen

DaptomycinLinezolidAnti-Bacterial Agents

Autor:innen und Institutionen

  • College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China.
  • Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen Nanshan People's Hospital and the Sixth Affiliated…
  • Laboratory of Respiratory Disease, People's Hospital of Yangjiang, Yangjiang 529500, China.

ORCID-Profile: Yanpeng Xiong, Zhong Chen, Zewen Wen

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • National Natural Science Foundation of China
  • Shenzhen Key Medical Discipline Construction Fund
  • Provincial medical funds of Guangdong
  • Shenzhen Nanshan District Scientific Research Program of the People?s Republic of China
  • Jiangsu Synergetic Innovation Center for Advanced Bio- Manufacture

Zitieren

APA

Xiong, Y., Chen, Z., Bai, B., Peng, Y., Liu, S., Fang, D., Wen, Z., Shang, Y., Lin, Z., Han, S., & Yu, Z. (2023). Thiazolopyrimidinone Derivative H5–23 Enhances Daptomycin Activity against Linezolid-Resistant Enterococcus faecalis by Disrupting the Cell Membrane. ACS Infectious Diseases, 9(12), 2523-2537. https://doi.org/10.1021/acsinfecdis.3c00387

Vancouver

Xiong Y, Chen Z, Bai B, Peng Y, Liu S, Fang D, et al. Thiazolopyrimidinone Derivative H5–23 Enhances Daptomycin Activity against Linezolid-Resistant Enterococcus faecalis by Disrupting the Cell Membrane. ACS Infectious Diseases. 2023;9(12):2523-2537. doi:10.1021/acsinfecdis.3c00387

BibTeX
@article{Xiong2023,
  author = {Xiong, Yanpeng and Chen, Zhong and Bai, Bing and Peng, Yalan and Liu, Shanghong and Fang, Di and Wen, Zewen and Shang, Yongpeng and Lin, Zhiwei and Han, Shiqing and Yu, Zhijian},
  title = {Thiazolopyrimidinone Derivative H5–23 Enhances Daptomycin Activity against Linezolid-Resistant Enterococcus faecalis by Disrupting the Cell Membrane},
  journal = {ACS Infectious Diseases},
  year = {2023},
  volume = {9},
  number = {12},
  pages = {2523--2537},
  doi = {10.1021/acsinfecdis.3c00387}
}
Kostenlos starten →